Last week, the Centers for Disease Control and Prevention (CDC) published an article in the Morbidity and Mortality Weekly Report (MMWR) titled “Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease — United States”

This article received a lot of attention in the media. However, not everyone was thrilled with the publication.

The Chief Executive Officer of LymeDisease.org, Lorraine Johnson, JD, MBA joined me to discuss the issues she has with the report–both scientific and ethical. In addition, Ms. Johnson discussed issues concerning chronic Lyme to include treatment and diagnosis–two issues that divide Lyme advocates and the CDC and the Infectious Diseases Society of America (IDSA).